Autumn Glory Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.15M Buy
48,050
+24
+0% +$2.12K 1.15% 23
2026
Q2
$3.76M Buy
48,026
+41,094
+593% +$3.32M 1.06% 23
2026
Q1
$601K Sell
6,932
-31,936
-82% -$3.06M 0.22% 106
2025
Q4
$3.73M Buy
38,868
+473
+1% +$45.9K 1.31% 14
2025
Q3
$3.66M Buy
38,395
+5,663
+17% +$521K 1.5% 12
2025
Q2
$2.85M Sell
32,732
-570
-2% -$48.3K 1.33% 15
2025
Q1
$3.26M Buy
33,302
+1,945
+6% +$174K 1.62% 10
2024
Q4
$2.5M Sell
31,357
-5,552
-15% -$481K 1.23% 21
2024
Q3
$3.32M Buy
36,909
+5,552
+18% +$467K 1.28% 17
2024
Q2
$2.47M Hold
31,357
– – 1.26% 20
2024
Q1
$2.73M Buy
31,357
+9,389
+43% +$801K 1.34% 17
2023
Q4
$1.81M Buy
21,968
+992
+5% +$75.6K 1.03% 29
2023
Q3
$1.64M Buy
20,976
+313
+2% +$26.2K 1% 33
2023
Q2
$1.82M Buy
+20,663
New +$1.78M 1.33% 25
2023
Q1
– Sell
-18,800
Closed -$1.46M – 164
2022
Q4
$1.46M Sell
18,800
-205
-1% -$16.6K 0.78% 38
2022
Q3
$1.54M Buy
19,005
+15,766
+487% +$1.42M 1.03% 32
2022
Q2
$291K Sell
3,239
-9,469
-75% -$959K 0.22% 103
2022
Q1
$1.41M Sell
12,708
-3,501
-22% -$370K 0.82% 40
2021
Q4
$1.68M Buy
+16,209
New +$1.88M 0.7% 46

Other funds holding MDT

Autumn Glory Partners's MDT Position: Q3 2026 in Review

Autumn Glory Partners increased its Medtronic (MDT) stake by 0.05% in Q3 2026, buying an estimated $2.12K and bringing the position to 48,050 shares worth $4.15M. The position accounts for 1.15% of the portfolio, ranked #23.

Autumn Glory Partners first reported a position in MDT in Q4 2021 and has held it in 19 quarters since. 2,189 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Autumn Glory Partners held 48,050 shares of Medtronic worth $4.15M as of Q3 2026.
  • Autumn Glory Partners bought 24 Medtronic shares in Q3 2026, an estimated $2.12K.
  • Medtronic made up 1.15% of Autumn Glory Partners's portfolio in Q3 2026, its #23 holding.
  • Autumn Glory Partners first reported a position in Medtronic in Q4 2021 and has held it in 19 quarters since.
  • 2,189 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Autumn Glory Partners's 13F filing for Q3 2026, filed 26 Oct 2026.